Jennifer Jannette

Stage IV CRC; MSS, atypical BRAF mut. Still kicking!

[Jennifer Jannette @JenniferJanne10]

@AlwaysSassy1961 @marklewismd @Intermountain @AltaViewHosp Wow, as a stage IV cancer patient for over 5 1/2 years, I beg to differ. Of that time I've had 30+ months of NED, watched my kids achieve great things, traveled many places and truly lived life all thanks to chemo & surgery. Your opinion is only your opinion...

[Ibrahim Halil SAHIN, MD @IbrahimSahinMD1]

✳️Our article on the value of ctDNA for management of patients with rectal cancer management is out ‼️

Thrilled to work with Dr @adasarimd on this one ‼️

✳️Some key points 👇

@manjuggm @CrcTrialsChat @colontown

[Fight Colorectal Cancer @FightCRC]

The FDA has approved the Shield blood test as a primary screening option for colorectal cancer, providing patients with more choices for screening.
Here is our response. 🧵

[Dr. Cathy Eng @CathyEngMD]

Interesting but early CAR-T results from @theNCI in @NatureMedicine: re: 7 #colorectal #cancer patients; 3 pts with response. However, median TTP= 4.6M. DOI: 10.1038/s41591-024-03109-0. Suggesting there may be a future role with additional research. #cancerresearch @OncoAlert #crcsm

[Yuman Fong @SoCalYuman]

307 outpatient robotic liver resections. 2% complications; 1.6% readmissions; 6 centers. @JeroenHagendoo1 @SoCalYuman @UW @HopkinsMedicine @cityofhope @CityofHopeSurg #MoreCuresLessInvasive

[Jennifer Jannette @JenniferJanne10]

@JJSingleton1 @ThanksCancer @FightCRC @ColonCancerCoal All the good juju coming your way!

[Pashtoon Kasi MD, MS @pashtoonkasi]

🆕🗞️Just out
🪺#NEST-1 trial results👇🏾

Are we on the verge of a new drug combo for colon or rectal cancer?

Substantial & brisk responses to just☝🏾dose of BOT🟢➕BAL🔹🔹 immunotherapy.🙌🏾

Pattern & kill is unprecedented🌊.

@ASCO #GI24 @OncoAlert
Abstract 117📍Poster Board H2

[Jennifer Jannette @JenniferJanne10]

@CathyEngMD A mom is a mom, whether your babe is 2 legged, 4 legged, fur, fins, feathers or scales! Happy Mothers Day!

[jj singleton @JJSingleton1]

Come join me @FightCRC my best friend @barefootostomy and 2 other incredible early age onset cancer survivors @erinverscheure @ulealexanderjr As we talk about life and everything with cancer as a young adult
Link below is to community of champions
https://t.co/4tueK0KJQH

[Fight Colorectal Cancer @FightCRC]

Last chance to register! Join @CathyEngMD and @CancerInsider tomorrow at 1 pm EST for a discussion on stage IV #ColorectalCancer. Even if you can't attend live we will send you recording!
https://t.co/czWL4A7byL

[Syed A. Ahmad @SyedAAhmad5]

Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials ⁦@JCO_ASCO⁩ https://t.co/vxcU6Ng4cY

[Mark Lewis, MD, FASCO @marklewismd]

Thank you for @AdairaLandryMD @Forbes for continuing to shine a light on the scourge that is early-onset colorectal cancer, cc: @KimmieNgMD @AustinChiangMD #crcsm #ayacsm

https://t.co/KaVCRJOe4w

[Ryan Nipp, MD, MPH, MBA, FASCO @RyanNipp]

The Benefits and Risks of Receiving Investigational Solid Tumor Drugs in Randomized Trials : A Systematic Review and Meta-analysis.

https://t.co/nE41TjNdDp

@AnnalsofIM @mcgillu
#CancerResearch #ClinicalTrials #Cancer #Oncology

[Fight Colorectal Cancer @FightCRC]

Navigating stage IV (metastatic) #ColorectalCancer treatment can be overwhelming. Join @CathyEngMD and @CancerInsider as they discuss stage IV #ColorectalCancer and answer your questions!

https://t.co/czWL4A7byL

[Phuong Gallagher @CancerInsider]

This is a really important topic for ALL CRC patients to understand, not just late stage patients or those interested in clinical trials. What should you be tested for? When should you be tested? Sign up and find out more!

[Kristen Ciombor @KristenCiombor]

Fantastic and inspiring talk about integrating palliative care with oncology care at Vanderbilt and beyond by our own Rajiv Agarwal @VUMCDiscoveries @VUMC_Cancer @benhopark @CathyEngMD @jordanberlin5

[Vanderbilt University Medical Center @VUMCDiscoveries]

Keith L. Obstein, M.D. (@KeithObstein), from @VUMC_GI provides an update on the development of groundbreaking robotic colonoscopy technology set to revolutionize the way colonoscopies are performed.

https://t.co/hw89Pfkp4h

[Ibrahim Halil SAHIN, MD @IbrahimSahinMD1]

✳️The first step for determination of therapeutic approach of patients with BRAF mutant CRC is defining the class of BRAF mutation ! Not all BRAF mutations are V600E mutants ❗️

✳️ Class II/III BRAF mutants (non-V600) are biologically distinct subgroups and patients with these mutants may derive benefit from EGFR blockade, particularly class III, which is kinase dead (little to no oncogenic activity)‼️

[Ibrahim Halil SAHIN, MD @IbrahimSahinMD1]

✳️Treatment of early onset CRC carry several nuances ‼️
✳️It is important to provide multi-D including sociopsychological support ‼️

For more 👇

https://t.co/gGIOZDUDzv

[Ibrahim Halil SAHIN, MD @IbrahimSahinMD1]

✳️For pts who have clinical symptoms, early referral is key‼️
✳️Diagnostic colonoscopy does not have any target age group unlike screening colonoscopy ‼️
✳️So important to differentiate these two ‼️
✳️Increased awareness of this concerning trend in health care providers is unmet need ‼️